Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06456242 Not yet recruiting - Smoking Cessation Clinical Trials

Contingency Management to Promote Smoking Cessation

Start date: July 2024
Phase: N/A
Study type: Interventional

Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.

NCT ID: NCT06442514 Not yet recruiting - Pain Clinical Trials

Pain and Smoking Study - Interactive Voice Response

PASS-IVR
Start date: December 1, 2024
Phase: N/A
Study type: Interventional

PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use Interactive Voice Response (IVR) to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.

NCT ID: NCT06435221 Not yet recruiting - Smoking Cessation Clinical Trials

Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers

ORCA-OL
Start date: May 24, 2024
Phase: Phase 3
Study type: Interventional

Safety assessment of long-term 3 mg cytisinicline three times daily (TID) exposure for 52 weeks is the main purpose of this study, conducted in the United States.

NCT ID: NCT06357767 Not yet recruiting - Smoking Cessation Clinical Trials

Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The goal of this project is to refine and test a culturally-tailored smoking cessation intervention for American Indian women who have experienced intimate partner violence (IPV). The primary aims of this study are to: (a) use a community-based participatory approach to refine intervention materials and finalize pilot intervention methodology for a culturally tailored, trauma-informed smoking cessation intervention for AI women who have experienced IPV; (b) examine feasibility, acceptability, satisfaction, and preliminary efficacy of the intervention; and (c) explore changes in alcohol and drug use over the course of the intervention. Participants will be asked to participate in the 8-week Healing Within: Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence, and complete interviews at baseline, end-of-treatment, and three months from the end of treatment.

NCT ID: NCT06307496 Not yet recruiting - Cancer Clinical Trials

VIDeOS for Smoking Cessation

Start date: September 2024
Phase: N/A
Study type: Interventional

The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.

NCT ID: NCT06303089 Not yet recruiting - Smoking Cessation Clinical Trials

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients

Start date: April 1, 2024
Phase:
Study type: Observational

The purpose of this study is to describe the tobacco exposure and characteristics of patients with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking cessation.

NCT ID: NCT06284369 Not yet recruiting - Smoking Cessation Clinical Trials

Video Messages for Smoking Cessation Campaign

Start date: May 2024
Phase: N/A
Study type: Interventional

240 adult smokers will be recruited. Subjects will be asked to view video messages that encourage smoking cessation. The effect of these videos will be assessed.

NCT ID: NCT06213532 Not yet recruiting - Smoking Cessation Clinical Trials

CONNECTing to LungCare

Start date: June 30, 2024
Phase: N/A
Study type: Interventional

This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.

NCT ID: NCT06187142 Not yet recruiting - Smoking Cessation Clinical Trials

Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The study aims to facilitate mobile phone-based cessation support for chronic patients using a sequential multiple assignment randomized trial (SMART) , and combines different effective treatments to enhance engagement and determine the most effective adaptive interventions.

NCT ID: NCT06148909 Not yet recruiting - Smoking Cessation Clinical Trials

Small Talk Intervention With MI for Smoking Cessation

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot study is to examine the effectiveness of the STMI in promoting abstinence in unmotivated smokers. The main questions it aims to answer are: - Do unmotivated smokers treated with STMI exhibit higher abstinence rate than those in the control group? - Do unmotivated smokers treated with STMI show higher intention to quit than those in the control group? - Do unmotivated smokers treated with STMI show higher smoking reduction rates than those in the control group? - Do unmotivated smokers treated with STMI show lower level of depressive symptoms than those in the control group? - Do unmotivated smokers treated with STMI show higher adherence than those in the control group? - Does STMI show higher consent rates than those the control? - How does STMI affect the smoking behaviors in unmotivated smokers? Participants will be randomized to (1) STMI or (2) control group for smoking cessation services via telephone, and then be invited to join a semi-structured interview.